Pfizer Updates Chantix Label To Cite Possible Risks
In the wake of alarming reports over Chantix, Pfizer Inc. has decided to update the label for its popular stop-smoking aid amid concerns that the drug increases depression and suicidal behavior...To view the full article, register now.
Already a subscriber? Click here to view full article